Fairman Group, LLC Castle Biosciences Inc Transaction History
Fairman Group, LLC
- $111 Billion
- Q3 2024
A detailed history of Fairman Group, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Fairman Group, LLC holds 13 shares of CSTL stock, worth $437. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 13
-0.0%
Holding current value
$437
Previous $283,000
31.1%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CSTL
# of Institutions
175Shares Held
25.6MCall Options Held
511KPut Options Held
130K-
Black Rock Inc. New York, NY3.04MShares$102 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.33MShares$78.3 Million0.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$53.1 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.54MShares$51.8 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.22MShares$40.9 Million0.44% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $885M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...